1.Phototherapy for Neonatal Hyperbilirubinemia.
Journal of the Korean Pediatric Society 1983;26(1):8-13
No abstract available.
Hyperbilirubinemia, Neonatal*
;
Phototherapy*
2.Correlation between the Gestational Age and Development of Renal Function in Preterm Infants.
Journal of the Korean Pediatric Society 1984;27(4):326-334
No abstract available.
Gestational Age*
;
Humans
;
Infant, Newborn
;
Infant, Premature*
3.Premature Rupture of Membranes and Its Effect on Neonatal Sepsis.
Journal of the Korean Pediatric Society 1984;27(12):1162-1167
No abstract available.
Membranes*
;
Rupture*
;
Sepsis*
4.clinical Observation on Neonatal Necrotizing Enterocolitis(Nec).
Journal of the Korean Pediatric Society 1985;28(5):423-434
No abstract available.
5.Clinical Assessment of Extrahepatic Biliary Atresia and Neonatal Hepatitis.
Journal of the Korean Pediatric Society 1984;27(1):33-42
No abstract available.
Biliary Atresia*
;
Hepatitis*
6.Clinical Observation of Neonatal Skin.
Kyu Han KIM ; Hee Chul EUN ; Chong Ku YUN
Journal of the Korean Pediatric Society 1984;27(11):1063-1069
No abstract available.
Skin*
8.Meta-analysis of Impact of Neonatal Intensive Care on Neurodevelopmental Outocme of Very Low Birth Weight Infants.
Beyong Il KIM ; Jung Hwan CHOI ; Chong Ku YUN
Journal of the Korean Pediatric Society 1994;37(7):937-945
We analyzed neurodevelopmental outcome data of 36 selected studies. Data of individual studies were pooled by birth weight group: <800g, <1.000g, <1.500g and by time period of birth year: Period I (pre-intensive care era), 1960-67:Period II (beginning period of intensive care), 1968-76: and Period III (established period of intensive care), 1977-87. In all weight groups, survival and intact outcome rates based on live birth have progressively improved over the three period. The major neurodevelopmental handicap rate of the <1,500g decreased in Period III vs. Period I and Period II (66,70, and 45 per 1,000 live births in I, II, and III, respectively). However, the major handicap rate in the <800g and the <1,000g live births increased: in the <800g, from 48 per 1,000 live births in Period II to 101 in Period III and, in the <1000g, from 28 per 1,000 live births in Period I to 67 in Period II and 73 in Period III. Increases in major handicap rate in two lower weight groups were predominantly the effect of increasing number of survivors over these periods and had little to do with the change in handicap rates in the survivors. In the <1,500g, the magnitude of reduction in handicap rate in the survivors was sufficient to overwhelm the effect of increased survival, resulting in a reduction in the number of major handicapped children. We conclude that based on the currently avaiable reports, neonatal intensive care has provided very low birth weight infants with a reduction in mortality, an increase in intact outcome, and decrease in the number of major neurodevelopmentally handicapped children. We try to estimate the trend of major neurodevelopmental handicap and intactoutcome of infants with birth weights <1,500g in Korea and speculate that major handicap rate have progressively increased over the three period in spite of increase in intact outcome.
Birth Weight
;
Disabled Children
;
Humans
;
Infant*
;
Infant, Newborn
;
Infant, Very Low Birth Weight*
;
Intensive Care, Neonatal*
;
Korea
;
Live Birth
;
Mortality
;
Parturition
;
Survivors
9.A Clinical Study of Childhood Non-Hodgkin's Lymphoma.
In Sang JEON ; Hyo Seop AHN ; Chong Ku YUN
Journal of the Korean Pediatric Society 1990;33(6):807-820
No abstract available.
Lymphoma, Non-Hodgkin*
10.Changes of Respiratory Indices and Clinical Response to the Different Modes of Delivery for Administration of Surfactant Replacement Therapy in the Respiratory Distress Syndrome.
Beyng Il KIM ; Jung Hwan CHOI ; Chong Ku YUN
Journal of the Korean Society of Neonatology 1997;4(2):205-216
PURPOSE: Factors affecting the response to surfactant replacement therapy are considered as types of surfactant, and strategies of treatment including prophylactic vs rescue therapy, single vs multiple doses, methods of mechanical ventilation, and modes of surfactant delivery. Among those factors, response to surfactant replacement therapy according to the modes of surfactant delivery was rarely studied in the world. In preterm infants with RDS, we studied the efficacy and adverse effects of surfactant replacernent therapy according to the differences in the modes of surfactant delivery. METHOD: Preterm infant weighing 500-2,500g with RDS who required assisted ventilation were divided into two groups. One group is as follows five fractional doses with five positional changes after removal from ventilator by feeding tube technique. The other group is as follows; two fractional doses with two positional changes by side-port adaptor technique. Of the 30 infants enrolled, 15 were randomly assigned to each group. We compared the respiratory indices, chest radiologic response, clinical outcome after surfactant replacement, and adverse effects during dosing procedure. RESULT: There were no diffrences of patient profile between two groups. There were significant improvernent in FiO2, a/APO2, MAP, OI, and chest radiologic response following surfactant replacement therapy in both groups. No significant differences were noted in the adverse effects during dosing procedure and incidence of complication. CONCLUSION: In initial phase of RDS treatment with surfactant replacement therapy, two fractional doses with two positional changes by side-port adaptor technique improve respiratory indices, radiologic response without dernonstrable harmful effects as five fractional doses with five positional changes after removal from ventilator by feeding tube technique, however two fractional dosing procedure is more recommendable because of #more simple and convenient procedure.
Humans
;
Incidence
;
Infant
;
Infant, Newborn
;
Infant, Premature
;
Respiration, Artificial
;
Thorax
;
Ventilation
;
Ventilators, Mechanical